PRL and breast cancer: Overall, we found that pSTAT5-positive breast cancer risk was increased for premenopausal women with high prolactin levels, suggesting that prolactin may be causally related to breast cancer risk in a subset of women through the traditional prolactin-related JAK-STAT pathway.